2wsa: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{Seed}} | {{Seed}} | ||
[[Image:2wsa. | [[Image:2wsa.png|left|200px]] | ||
<!-- | <!-- | ||
Line 12: | Line 12: | ||
===CRYSTAL STRUCTURE OF LEISHMANIA MAJOR N-MYRISTOYLTRANSFERASE (NMT) WITH BOUND MYRISTOYL-COA AND A PYRAZOLE SULPHONAMIDE LIGAND (DDD85646)=== | ===CRYSTAL STRUCTURE OF LEISHMANIA MAJOR N-MYRISTOYLTRANSFERASE (NMT) WITH BOUND MYRISTOYL-COA AND A PYRAZOLE SULPHONAMIDE LIGAND (DDD85646)=== | ||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_20360736}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 20360736 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_20360736}} | |||
==About this Structure== | ==About this Structure== | ||
Line 17: | Line 23: | ||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID:12488459</ref><references group="xtra"/> | <ref group="xtra">PMID:20360736</ref><ref group="xtra">PMID:12488459</ref><references group="xtra"/> | ||
[[Category: Glycylpeptide N-tetradecanoyltransferase]] | [[Category: Glycylpeptide N-tetradecanoyltransferase]] | ||
[[Category: Leishmania major]] | [[Category: Leishmania major]] | ||
Line 31: | Line 37: | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Apr 14 09:06:14 2010'' |
Revision as of 09:06, 14 April 2010
CRYSTAL STRUCTURE OF LEISHMANIA MAJOR N-MYRISTOYLTRANSFERASE (NMT) WITH BOUND MYRISTOYL-COA AND A PYRAZOLE SULPHONAMIDE LIGAND (DDD85646)CRYSTAL STRUCTURE OF LEISHMANIA MAJOR N-MYRISTOYLTRANSFERASE (NMT) WITH BOUND MYRISTOYL-COA AND A PYRAZOLE SULPHONAMIDE LIGAND (DDD85646)
Template:ABSTRACT PUBMED 20360736
About this StructureAbout this Structure
2WSA is a 1 chain structure with sequence from Leishmania major. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Frearson JA, Brand S, McElroy SP, Cleghorn LA, Smid O, Stojanovski L, Price HP, Guther ML, Torrie LS, Robinson DA, Hallyburton I, Mpamhanga CP, Brannigan JA, Wilkinson AJ, Hodgkinson M, Hui R, Qiu W, Raimi OG, van Aalten DM, Brenk R, Gilbert IH, Read KD, Fairlamb AH, Ferguson MA, Smith DF, Wyatt PG. N-myristoyltransferase inhibitors as new leads to treat sleeping sickness. Nature. 2010 Apr 1;464(7289):728-32. PMID:20360736 doi:10.1038/nature08893
- ↑ Price HP, Menon MR, Panethymitaki C, Goulding D, McKean PG, Smith DF. Myristoyl-CoA:protein N-myristoyltransferase, an essential enzyme and potential drug target in kinetoplastid parasites. J Biol Chem. 2003 Feb 28;278(9):7206-14. Epub 2002 Dec 17. PMID:12488459 doi:10.1074/jbc.M211391200
Page seeded by OCA on Wed Apr 14 09:06:14 2010